menu
    • menu

    Company profile for BioNTech

    NEW Drugs in Dev: 64
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioNTech SE is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all of the building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen ...
    BioNTech SE is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all of the building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioNTechGermany Flag
    Country
    Country
    Germany
    Address
    Address
    An der Goldgrube 12 D-55131 Mainz
    Telephone
    Telephone
    +49-6131-9084-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biontech.com/int/en/home.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biontech-ag
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biontech_group?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioNTech Closes Singapore mRNA Site in Pipeline Shift
    BioNTech Closes Singapore mRNA Site in Pipeline Shift

    03 Apr 2026

    // BIOSPACE

    https://www.biospace.com/business/biontech-starts-shuttering-singapore-mrna-manufacturing-site-amid-pipeline-pivot

    BIOSPACE
    03 Apr 2026
    Share Share
    Biontech To Turn Out The Lights At Singapore Vaccine Facility
    Biontech To Turn Out The Lights At Singapore Vaccine Facility

    02 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/biontech-telegraphs-closure-singapore-mrna-facility-amid-efforts-align-capacity

    FIERCE PHARMA
    02 Apr 2026
    Share Share
    Pfizer, BioNTech Halt US COVID Vaccine Trial Over Safety Issues
    Pfizer, BioNTech Halt US COVID Vaccine Trial Over Safety Issues

    02 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/pfizer-biontech-halt-large-us-covid-19-vaccine-trial-over-slow-enrollment

    BIOSPACE
    02 Apr 2026
    Share Share
    Pfizer, BioNTech halt COVID vaccine study after struggles
    Pfizer, BioNTech halt COVID vaccine study after struggles

    01 Apr 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-halt-us-covid-vaccine-study-after-recruitment-struggles-2026-04-01/

    REUTERS
    01 Apr 2026
    Share Share
    Biontech Clinical Data At ELCC 2026 Showcases Lung Cancer
    Biontech Clinical Data At ELCC 2026 Showcases Lung Cancer

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261033/0/en/BioNTech-Clinical-Data-at-ELCC-2026-Highlight-Potential-of-Differentiated-Late-Stage-Portfolio-in-Lung-Cancer.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    BioNTech Founders To Leave Famed mRNA Biotech For New Venture
    BioNTech Founders To Leave Famed mRNA Biotech For New Venture

    11 Mar 2026

    // BIOSPACE

    https://www.biospace.com/business/biontech-founders-to-leave-famed-mrna-biotech-for-new-venture

    BIOSPACE
    11 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search